The gamble between oncolytic virus therapy and IFN

56Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Various studies are being conducted on oncolytic virotherapy which one of the mechanisms is mediating interferon (IFN) production by it exerts antitumor effects. The antiviral effect of IFN itself has a negative impact on the inhibition of oncolytic virus or tumor eradication. Therefore, it is very critical to understand the mechanism of IFN regulation by oncolytic viruses, and to define its mechanism is of great significance for improving the antitumor effect of oncolytic viruses. This review focuses on the regulatory mechanisms of IFNs by various oncolytic viruses and their combination therapies. In addition, the exerting and the producing pathways of IFNs are briefly summarized, and some current issues are put forward.

Cite

CITATION STYLE

APA

Li, Q., Tan, F., Wang, Y., Liu, X., Kong, X., Meng, J., … Cen, S. (2022, August 25). The gamble between oncolytic virus therapy and IFN. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2022.971674

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free